Abstract:
Minerva Biotechnologies Corp. has raised about $4.6 million of planned $5.9 million equity offering, according to a filing with the U.S. Securities and Exchange Commission. In addition to equity, the regulatory filing notes that the Waltham biotech firm is offering warrants that could amount to $1.13 million more.